Ocrevus Start Form By Genentech: Streamlined Access Made Easy

Quick Links :

The journey to accessing life-changing treatments can be daunting, especially for patients with complex conditions like multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS). To help alleviate some of the burdens associated with accessing these treatments, Genentech has introduced the Ocrevus Start Form, a streamlined process designed to make it easier for patients to initiate therapy with Ocrevus (ocrelizumab).

For many patients, the path to treatment can be long and arduous, involving multiple stakeholders, paperwork, and waiting periods. This can lead to frustration, anxiety, and delays in accessing the care they need. The Ocrevus Start Form is designed to simplify this process, reducing the administrative burden on healthcare providers and patients, and helping to ensure that those who need Ocrevus can start treatment sooner.

Benefits of the Ocrevus Start Form

The Ocrevus Start Form offers several benefits, including:

• Streamlined enrollment: The form allows healthcare providers to enroll patients in the Ocrevus Start program quickly and easily, reducing the administrative burden and saving time.
• Simplified patient access: The program provides patients with a single point of contact for access to Ocrevus, making it easier for them to navigate the treatment initiation process.
• Enhanced support: The Ocrevus Start program offers patients and healthcare providers access to dedicated support services, including patient education and assistance with reimbursement and access.

How the Ocrevus Start Form Works

The Ocrevus Start Form is a simple, three-step process:

1. Enrollment: Healthcare providers enroll patients in the Ocrevus Start program by completing a brief form.
2. Verification: The patient's insurance coverage and eligibility for Ocrevus are verified.
3. Treatment initiation: Once enrollment and verification are complete, patients can start treatment with Ocrevus.

Eligibility and Access

To be eligible for the Ocrevus Start program, patients must:

• Have a confirmed diagnosis of relapsing or primary progressive multiple sclerosis (RRMS or PPMS)
• Have a prescription for Ocrevus from a licensed healthcare provider
• Have commercial insurance coverage or be uninsured

Support Services

The Ocrevus Start program offers a range of support services to help patients and healthcare providers navigate the treatment initiation process. These services include:

• Patient education: Educational resources and support to help patients understand their treatment and manage their condition.
• Reimbursement assistance: Assistance with reimbursement and access to help patients overcome financial barriers to treatment.
• Dedicated support: A dedicated support team to answer questions and provide support throughout the treatment initiation process.

Conclusion

The Ocrevus Start Form is a valuable resource for patients with MS and PPMS, offering a streamlined and supportive pathway to accessing Ocrevus. By simplifying the enrollment process and providing dedicated support services, Genentech is helping to ensure that patients can start treatment sooner and focus on managing their condition.

We invite you to share your thoughts and experiences with the Ocrevus Start Form. How has this program helped you or your patients? What benefits have you seen? Share your comments below.